These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29087218)

  • 1. Design, characterization and antimalarial efficacy of PEGylated galactosylated nano lipid carriers of primaquine phosphate.
    Baruah UK; Gowthamarajan K; Ravisankar V; Karri VVSR; Simhadri PK; Singh V; Babu PP
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1809-1829. PubMed ID: 29087218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactose-Anchored Gelatin Nanoparticles for Primaquine Delivery and Improved Pharmacokinetics: A Biodegradable and Safe Approach for Effective Antiplasmodial Activity against P. falciparum 3D7 and in Vivo Hepatocyte Targeting.
    Kumar H; Gothwal A; Khan I; Nakhate KT; Alexander A; Ajazuddin ; Singh V; Gupta U
    Mol Pharm; 2017 Oct; 14(10):3356-3369. PubMed ID: 28836792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles.
    Omwoyo WN; Ogutu B; Oloo F; Swai H; Kalombo L; Melariri P; Mahanga GM; Gathirwa JW
    Int J Nanomedicine; 2014; 9():3865-74. PubMed ID: 25143734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimisation of chloroquine phosphate loaded nanostructured lipid carriers using Box-Behnken design and its antimalarial efficacy.
    Baruah UK; Gowthamarajan K; Ravisankar V; Karri VVSR; Simhadri PK; Singh V
    J Drug Target; 2018 Aug; 26(7):576-591. PubMed ID: 29057679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning prioritizes synthesis of primaquine ureidoamides with high antimalarial activity and attenuated cytotoxicity.
    Levatić J; Pavić K; Perković I; Uzelac L; Ester K; Kralj M; Kaiser M; Rottmann M; Supek F; Zorc B
    Eur J Med Chem; 2018 Feb; 146():651-667. PubMed ID: 29407988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphiphilic dendritic derivatives as nanocarriers for the targeted delivery of antimalarial drugs.
    Movellan J; Urbán P; Moles E; de la Fuente JM; Sierra T; Serrano JL; Fernàndez-Busquets X
    Biomaterials; 2014 Sep; 35(27):7940-50. PubMed ID: 24930847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization, and cellular localization of a fluorescent probe of the antimalarial 8-aminoquinoline primaquine.
    McQueen A; Blake LD; Azhari A; Kemp MT; McGaha TW; Namelikonda N; Larsen RW; Manetsch R; Kyle DE
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4597-4600. PubMed ID: 28939120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primaquine Loaded Solid Lipid Nanoparticles (SLN), Nanostructured Lipid Carriers (NLC), and Nanoemulsion (NE): Effect of Lipid Matrix and Surfactant on Drug Entrapment, in vitro Release, and ex vivo Hemolysis.
    Wu KW; Sweeney C; Dudhipala N; Lakhani P; Chaurasiya ND; Tekwani BL; Majumdar S
    AAPS PharmSciTech; 2021 Sep; 22(7):240. PubMed ID: 34590195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis.
    Pradhan M; Singh D; Murthy SN; Singh MR
    Steroids; 2015 Sep; 101():56-63. PubMed ID: 26049018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicological study of the primaquine phosphate loaded chitosan nanoparticles in mice.
    Rajera R; Nagpal K; Singh SK; Mishra DN
    Int J Biol Macromol; 2013 Nov; 62():18-24. PubMed ID: 23973494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic efficacy of a regimen of artesunate-mefloquine-primaquine treatment for Plasmodium falciparum malaria and treatment effects on gametocytic development].
    Vásquez AM; Sanín F; Alvarez LG; Tobón A; Ríos A; Blair S
    Biomedica; 2009 Jun; 29(2):307-19. PubMed ID: 20128355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of primaquine and chloroquine with PEGylated phosphatidylcholine liposomes.
    Miatmoko A; Nurjannah I; Nehru NF; Rosita N; Hendradi E; Sari R; Ekowati J
    Sci Rep; 2021 Jun; 11(1):12420. PubMed ID: 34127730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primaquine and Chloroquine Fumardiamides as Promising Antiplasmodial Agents.
    Beus M; Fontinha D; Held J; Rajić Z; Uzelac L; Kralj M; Prudêncio M; Zorc B
    Molecules; 2019 Aug; 24(15):. PubMed ID: 31374989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
    Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A
    Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Phenoxy Primaquine Analogs and the Tetraoxane Hybrid as Antimalarial Agents.
    Jansongsaeng S; Srimongkolpithak N; Pengon J; Kamchonwongpaisan S; Khotavivattana T
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34208832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
    Song A; Zhang X; Li Y; Mao X; Han F
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
    Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
    Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of arteether-loaded nanostructured lipid carriers for the treatment of malaria.
    Ali Z; Mishra N; Baldi A
    Artif Cells Nanomed Biotechnol; 2016; 44(2):545-9. PubMed ID: 25340261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.